Member Info for Vascular

This is more recent, dated 27th Nov.

Valid tests should include PCR, Rapid Point of Care LAMP and lateral flow technologies used by government in other settings, with no diversion from NHS testing capacity. This coincides with the start of the UK ‘test to release’ regime on day five to generate critical data and support the removal of quarantine for international arrivals.

https://www.aviation24.be/airlines/virgin-atlantic/launches-pre-departure-covid-19-testing-trial-on-heathrow-barbados-flights/

The SP can't just stand still at £1 until the next piece of news, and then rise just to suite anyone who happens to be invested here. There has been absolute radio silence from ODX for ages now, for whatever reason....and that's why the SP is where it is........meanwhile, my main hope is that the ODX staff are busy building out more capacity during this time.......because thats what will ultimate make this share price rise. Yes, positive announcements temporarily make the sp rise, and then fall, but the thing that's going to multibag this SP is constant, increasing manufacturing output...no point in having the deals if you can't honor them....

Whats the manufacturing capacity in Hamburg? What about the new Indian facility? Surely these facilities were not included in previous projections. I would have liked this information published a little bit more than a random find on youtube ( thanks to Scaff 55)

Sounded like they are "Building a manufacturing facility" to work alongside their sales and marketing offices in India Pune and Mumbai?
This really does sound like a company that knows it has orders, just waiting to be claimed once they have the manufacturing capacity....if so, its just a matter of waiting.

most start on early December and looks like wholesale testing of students before they return home for xmas. looks like they are using a self test, with result handed in after results.
The JD states
". The key Responsibilities that we are looking for are-
* To provide verbal support to subject registering on their device.
* Adds patient to the register if not already registered, and provides support if QR code is not scanning.
* If patient cannot use own device, requests verbal consent from subject to complete registration on their behalf.
* Provides testing kit to patient to take to the booth.
* Directs subject to available booth.
https://www.google.com/search?rlz=1C1CHBF_en-GBGB768GB768&sxsrf=ALeKk02Pe0RazjF2Ys1lw-7tQUHikSgdAQ:1606420569613&ei=WQjAX_XmJMKigQbl0rioBg&q=covid+Registration+Assistants+jobs&oq=covid+Registration+Assistants+jobs&gs_lcp=CgZwc3ktYWIQA1CoNVigXWDsYGgAcAB4AIABggGIAYIGkgEDMy41mAEAoAEBqgEHZ3dzLXdpesABAQ&sclient=psy-ab&uact=5&ibp=htl;jobs&sa=X&ved=2ahUKEwiekrqH_6DtAhWEUMAKHao1AwcQudcGKAJ6BAgDECg#htivrt=jobs&htidocid=g-bv9vXu9TbglZ_fAAAAAA%3D%3D&fpstate=tldetail

That fit nicely with this press release yesterday. A change is coming....
"Today, I am grateful for the opportunity to update on our plans to significantly expand testing. This further expansion is possible because of increases in our testing capacity - coming from the 3 new NHS regional hub laboratories, from Lighthouse laboratories, and from new testing options. New options come from innovation in testing outside our labs – notably the new lateral flow devices – bringing us significantly greater capability to test more people, more often.

I will come on to how we will use this capability, but first, I would like to say a few words on these new tests. Lateral Flow Devices are rapid turnaround tests, where samples are processed on site with no lab required and results are available in under half an hour. The type we are using first in our expansion – the Innova lateral flow test – has had extensive clinical validation by Public Health England and Oxford University. .....and so on.."

https://www.gov.scot/publications/covid-testing-strategy-health-secretarys-statement-wednesday-25-november-2020/

"I really don’t see a difference between a doctor doing this or an adult individual. It has instructions with it so what is the hold up in approving."
I thought the hold up was more around what is done with the information/ data once someone tested themselves, is it just for personal knowledge or should it be uploaded to government main data base / with location GPS etc - so Gov. can keep track of the numbers and locations. As someone rightly said diabetics have being their own blood test by the millions each day, and no one carers about them lol
Isn't that why Abbington Health have brought out their new whizzy APP.
"AppDx® is cutting-edge mHealth software that turns a Smartphone into a lateral flow reader. By utilising cameras and connectivity within Smartphones, AppDx® enables data to be captured from rapid tests and shared to secure data silos and connected stakeholders.

"AppDx’s provision of lab-quality results in any location creates flexible testing solutions and allows real-time health monitoring and management.....record data relating to patients, assays, testing locations, time and dates and results"

https://www.abingdonhealth.com/contract-services/lateral-flow-reader/appdx/

The jury is still out from what I understand....time , a lot of time will tell.

Symbol1. "When considering whether this share has legs just ask yourself why would colin even contemplate this unless he was bullet proof sure he was going to sell every last test of any kind. The multiples being geared up are staggering ".

There are many unknowns here, some half knowns and some things you have to take on what some people would call logic, and others call trust.....trust that Colin is of sound mind and has indeed got future business pretty much guaranteed, before he went on a spending spree to ramp up production to such a mega proportions........

Someone mentioned ODX alone could be manufacturing 300,000 per day now, well lets say 200,000 , and a 1 million a week.....where are these all going....customer or storage?

"Only between 4% and 6% of the population has COVID-19 antibodies, which suggests that most of the population is still vulnerable to the virus (September to October)"

The question is ... without antibody testing no one knows who's got what, which areas are worse than others, which vaccines work best with different sub sectors of the population and what's going on in the population at large any one time. So i think we can all agree that throughout the world testing of all types will become the new norm.....so anyone invested here, all they need to know is that ODX are able to maximize this opportunity and make as many tests as they can possibly sell ....
That's the reward here is very simple, nothing more and nothing less... HIV and Food testing can be seen as insurance.
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19weeklyinsights/latesthealthindicatorsinengland20november2020

As mentioned in the Walbrook reply. The UK RTC will ensure that their Close relationship ( although not contractual) will be reflected in their promotion of their rapid tests throughout the world. It's. Hard to believe that the success of the Oxford /AZ vaccine throughout the world will not highlight the UK consortiums antibody test and produce large orders from the billions of vaccines that have been pre ordered throughout the world......there's got to be mega $ oppurtunitys in just this relationship alone.....

I contacted Walbrook last week and posted the reply here. I can confirm my reply was very similar to Handome1.
Thank for posting this. I believe that the hands are tied for the time being, but this could change any day.

Someone was asking for confirmation earlier of how many doses of the Oxford / AZ vaccine had been pre ordered.

"Oxford University’s collaboration with AstraZeneca has been crucial to the successful development of the vaccine and vital for its global manufacturing and distribution across the world. AstraZeneca already has international agreements in place to supply three billion doses of the vaccine, with access being built through more than 30 supply agreements and partner networks.
https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine

Now, we know that the Oxford / AZ vaccine and the antibody test were developed together - what we need is some evidence that Oxford / AZ could also include / promote / supply this test as an accessory / or add on to their vaccine.
https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine

Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
The study calculated the sensitivity (the ability of a test to correctly identify those with SARS-CoV-2 antibodies or ‘true positive’ rate) and the specificity (the ability of the test to correctly identify those without SARS-CoV-2 antibodies or ‘true negative’ rate).
https://www.ox.ac.uk/news/2020-09-28-comparison-five-tests-used-detect-covid-19-antibodies-shows-siemens-and-oxford

TWatcher.

Its me again. It seems that Roche have their own antibody test, as have Oxford/ AZ.
"The test is the latest addition to the comprehensive Roche diagnostic portfolio to help healthcare systems combat COVID-19 through testing in the laboratory and at the point of care"......"Performing a combination of the Elecsys Anti-SARS-CoV-2 S and Elecsys Anti-SARS-CoV-2 tests can also help to more effectively define what percentage of a given population has developed antibodies (seroprevalence) against SARS-COV-2, especially in low to moderate seroprevalence settings.3 Knowing a given population’s seroprevalence is important in understanding how to contain the spread of the virus, as well as how to safely ease lockdown restrictions."

Why would they bother , if it was not required.
https://www.roche.com/investors/updates/inv-update-2020-09-18b.htm

Session 2?—?13.00 to 14.30: Challenge: Security & Information Governance

Leigh Thomas, Senior VP,

Director of Global Sales, Abingdon Health

The Challenges in Developing a Smartphone Rapid Test Reader Solution – the AppDx Experience

https://www.uk-cpi.com/events/medilink

This news is several months old but It looks very much like the Abbingdon Health and the UK-Rapid Test Consortium have been working in partnership with NHSX – the technology, digital and data service of the NHS..... to develop a test specific app and digital service that will facilitate the use and reading of the test device. This will have the ability to integrate with NHS systems and update records !!!
https://www.rapidmicrobiology.com/news/uk-begin-at-home-covid-19-antibody-testing-programme

https://www.mirror.co.uk/lifestyle/health/dr-miriam-stoppard-mass-antibody-23013829

"point me to a covid document, from either a government or vaccine provider, or a good research paper, indicating that mass antibody testing is going to be required as part of a vaccine roll out. No one has has done so."

Hi TWatcher. How does this sound. The 10 million is just the beginning.....apparently.

"The UK recently signed a contract with leading biotech companies Roche and Abbott for the supply of over 10,000,000 Covid-19 antibody tests. This number of tests would determine the immunity status for approximately 15% of the UK’s population. Although more testing will be necessary for a comprehensive understanding of the nation’s immunity to Covid-19, this is certainly a step in the right direction for the UK’s five key pillar national testing strategy, which was announced by the secretary of state on 2 April. Pillar three outlines mass antibody testing to help determine whether individuals have immunity to Covid-19.
https://medical-technology.nridigital.com/medical_technology_jun20/covid-19_antibody_tests_uk_testing_strategy

MR PROFIT
@profit_is_king
#ODX 3bn+ Gold Standard Antibody tests will be needed along side with AstraZeneca Vaccine Winking face
11:03 AM · Nov 23, 2020·Twitter for Android
https://twitter.com/profit_is_king/status/1330829306247974912